BEVERLY HILLS, California, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial ...

At the European Society for Medical Oncology (ESMO) 2025 event, held in Berlin, Germany, between 17-21 October, Celcuity ...

In this special edition of the Student Notebook, early-career scholars from across the APSSC community share their ...

Nuclear fusion, which operates on the same principle that powers the Sun, is expected to become a sustainable energy source for the future. To achieve ...

Your brain’s “emergency brake” goes quiet during rival defeats. Highly engaged fans showed reduced activity in the brain region that normally keeps aggressive impulses in check, potentially explaining ...

At seventy-three, the former front man of Talking Heads is still asking questions about what it means to be alive. But now he ...

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...

Akeso has data showing ivonescimab can extend the lives of patients with previously treated EGFR-mutated non-small cell lung ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that biomarker data and updated clinical ...

This paper introduces a novel AI-enhanced retirement planning platform that integrates behavioral economics principles with advanced machine learning techniques to optimize financial decision-making.

Research reveals that brief, structured micro-breaks, under ten minutes, significantly enhance student attention and learning ...